Viracta Therapeutics, Inc. (VIRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0162
+0.0003 (1.82%)
Jul 3, 2025, 4:00 PM EDT
Viracta Therapeutics Market Cap
Viracta Therapeutics has a market cap or net worth of $645.45 thousand as of July 3, 2025. Its market cap has decreased by -97.47% in one year.
Market Cap
645.45K
Enterprise Value
-3.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since February 25, 2021, Viracta Therapeutics's market cap has decreased from 8.68M to 645.45K, a decrease of -92.57%. That is a compound annual growth rate of -44.96%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 3, 2025 | 645.45K | -89.91% |
Dec 31, 2024 | 6.39M | -70.95% |
Dec 29, 2023 | 22.02M | -60.52% |
Dec 30, 2022 | 55.77M | -59.05% |
Dec 31, 2021 | 136.19M | 1,468.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.60B |
Veradigm | 823.67M |
Nika Pharmaceuticals | 708.22M |
Elite Pharmaceuticals | 639.84M |
Tian'an Technology Group | 628.15M |
Glass House Brands | 557.29M |
American Oncology Network | 418.01M |
Northwest Biotherapeutics | 366.72M |